JAMES M FRATES

CIK 1235598 · Chief Financial Officer · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.98M

Companies

3

Total Filings

210

Lifetime Open-Market Net

-$42.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMLX Chief Financial Officer 361,628 $14.59 $5.28M -$3.22M 23 2026-03-09
Sage Therapeutics, Inc. (SAGE) Delisted Director 1,810 $8.68 $15.7K -$4.48M 21 2025-07-31
ALKS SVP, Alks Inc; CFO ALKS 241,828 $44.28 $10.71M -$34.81M 166 2020-05-14

Recent Filings · Page 2 of 21

210 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-09-16 AMLX Buy (P) +40,000 $101.4K EDGAR
2024-09-05 AMLX Exer (M) +18,165 $125.0K EDGAR
2024-06-11 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2024-04-18 AMLX Grant (A) +91,180 $0 EDGAR
2024-03-07 AMLX Sell (S) −1,792 -$33.6K EDGAR
2024-02-28 AMLX Grant (A) +40,000 $0 EDGAR
2024-01-11 AMLX Sell (S) −2,716 -$44.3K EDGAR
2024-01-04 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2023-11-02 AMLX Gift (G) +11,072 $0 EDGAR
2023-08-24 AMLX Exer (M) +18,165 $125.0K EDGAR
Showing 1120 of 210
Page 2 of 21
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.